Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"The early results released from the Nice Insight survey highlight how much
work companies need to do to improve customer awareness and perception. This
type of marketing intelligence is not easily available, which is what makes
the Nice Insight product offering appealing as a tool to aid strategic
decision-making."
CLIFF BRIDGES GLOBAL MARKETING & HR COMMUNICATIONS DIRECTOR OF PGI  
CPhI Worldwide
October 22-24 Messe Frankfurt, Germany |
Akorn Boehringer Ingelheim GmbH Cedarburg Hauser Pharmaceuticals Inc. Cook Pharmica Galenix Inc. Hisun Pharmaceuticals USA, Inc. IDT Biologika GmbH Oso BioPharmaceuticals Manufacturing, LLC Piramal Healthcare Pharma Solutions Vetter
PCI Synthesis, Inc. is a custom manufacturer of new chemical entities, generic APIs, and other specialty chemical products. Services include process research, process development, analytical development, process validation, regulatory support and FDA filing, as well as custom development and manufacturing. The company’s products are used as raw materials and reagents in the pharmaceutical, biopharmaceutical and nanotechnology industries, among others. The company presents itself as PolyCarbon Industries, Inc. doing business as PCI Synthesis, Inc.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
